Purpose. To review the outcome of total elbow replacement (TER) in 21 patients after a mean of 64 months. Methods. Records of 12 women and 9 men aged 32 to 78 (mean, 59.1) years who underwent 22 TERs for rheumatoid arthritis by a single surgeon were reviewed. Functional outcome was assessed using the disability of the arm, shoulder and hand (DASH) questionnaire. The range of movement and KaplanMeier survival curve was determined. Adequacy of cementation was assessed on immediate postoperative radiographs. Aseptic loosening was assessed on radiographs using the Mayo clinic scoring system. Results. After a mean follow-up of 64 (range, 10-145) months, the mean DASH score improved from 72.3 to 46.8, mean flexion improved from 96.9º to 128.1º, and mean extension lag from 37.3º to 24.0º. The 5-year survival rate with symptomatic aseptic loosening as the end point was 100%, and the revision rate for all reasons was 69%. Cement mantle was adequate
in 17, marginal in 4 (most lacked cement around the prosthesis tip), and inadequate in one who was clinically asymptomatic. At the latest follow-up, 4 patients had a type-1 radiolucent line and one had a type-2 radiolucent line of both components; all remained clinically asymptomatic. Two patients developed transient radial nerve neuropraxia. One patient underwent revision for peri-operative fracture. One patient underwent a 2-stage revision for deep infection. One patient underwent revision for bilateral periprosthetic fracture. One patient underwent revision for symptomatic aseptic loosening. No patient had elbow dislocation. Conclusion. TER is a viable option for pain relief and functional improvement in patients with rheumatoid arthritis.
introduction
Total elbow replacement (TER) is a viable surgical option for patients with pain secondary to rheumatoid arthritis. 1,2 Its annual incidence is 1.4 per 100 000 population and the incidence has reduced 15% over the past 15 years, 1 owing to the use of diseasemodifying anti-rheumatoid drugs. The outcome of TER is not as good as that of total knee or hip arthroplasty. The survival rate of TER with aseptic loosening as the end point has been 90-100% at 5 years, [3] [4] [5] and 85-93% at 10 years. 1, 6, 7 The complication rate of TER can be as high as 45%, 8 but has declined to 24.3% with the introduction of new implant designs. 9 The complication rate for the CoonradMorrey prosthesis is 18.2-19.4%, 3, 7 with loosening, stiffness, and periprosthetic fracture being the most common. This study reviewed the outcome of TER in 21 patients after a mean of 64 months.
Materials and Methods
Records of 12 women and 9 men aged 32 to 78 (mean, 59.1) years who underwent 22 TERs using the Coonrad-Morrey prosthesis for rheumatoid arthritis by a single surgeon between 2000 and 2012 were reviewed.
The posterior Mayo triceps-splitting approach was used. The humeral side was prepared first followed by the ulnar side. After a trial reduction, the prosthesis was fixed with polymethylmetharcylate bone cement (Palacos).
Pre-and post-operative outcome was compared. Functional outcome was assessed using the disability of the arm, shoulder and hand (DASH) questionnaire. The range of movement was measured. Kaplan-Meier survival curve was determined with symptomatic aseptic loosening as the end point. Adequacy of cementation was assessed on immediate postoperative radiographs. 10 Aseptic loosening was assessed on radiographs using the Mayo clinic scoring system.
results
After a mean follow-up of 64 (range, In immediate postoperative radiographs of the 22 TERs, cement mantle was adequate in 17, marginal in 4 (most lacked cement around the prosthesis tip), and inadequate in one who was clinically asymptomatic and had not undergone revision after 74 months. At the latest follow-up, 4 patients had a type-1 radiolucent line and one had a type-2 radiolucent line of both components; all remained clinically asymptomatic.
Two patients developed transient radial nerve neuropraxia; one occurred immediately postoperatively and resolved within 2 weeks, and the other occurred at 6 weeks and resolved at 3 months. One patient underwent revision for peri-operative fracture. One patient on steroids underwent a 2-stage revision for deep infection. One patient underwent revision for bilateral periprosthetic fracture secondary to a low-energy trauma in the first episode and during driving in the second episode. One patient underwent revision for symptomatic aseptic loosening. No patient had elbow dislocation. Three patients died from unrelated causes.
discussion
The outcome of TER has been good in terms of the rate of survival and complications (Table) . In our patients, the survival rate was comparable with that in the literature, but the complication rate was much higher. Rheumatoid arthritis of the elbow is difficult to manage medically and requires prolonged prescription of steroids and immunosuppressants. This increases the risk of infection. The periprosthetic fracture rate has been reported to be 1.3%. incidence is higher in surgeons performing >10 cases per year than in those performing fewer. 1 The Mayo elbow performance score (MEPS) is commonly used for evaluation of function following TER. 3, 7 In our study, the DASH questionnaire was used. It is completed by the patient and correlates with the MEPS. In our patients, poor cementing did not appear to affect aseptic loosening, probably owing to the low demand of patients.
conclusion

